Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Evaluation of Genexus System for Rapid Comprehensive Genomic Profiling of Myeloid Malignancies in Clinical Samples

Association for Molecular Pathology Annual Meeting
AMP 2022

Phoenix, AZ, Nov  1 - 5, 2022

Poster presentation: Evaluation of Genexus System for rapid comprehensive genomic profiling of myeloid malignancies in clinical samples

Authors: Maharjan N, Dhungana S, Blakely K, Powers SB, Freitas TAK, Sun G, Glidewell SC, Khadgi S, Kilaru GK, Tigh AD,  Graham JA, Blann L, Zhang J, Champion KJ

Specialties: Genetics, Oncology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.